In a previous study, obacunone attenuated ulcerative colitis symptoms in mice by modulating the gut microbiota, disrupting the TLR4/NF-κB signaling cascades, and restoring intestinal epithelial barrier integrity (Luo et al., 2020). Here, NFKB1 is linked to ulcerative colitis.